Today, researchers and clinicians are under great pressure to develop therapies capable of reversing or significantly impacting the progression of disease. In recent years, the arrival of the cell and gene therapy industries have introduced the possibility of providing transformative, durable and potentially curative outcomes for a diverse range of life-threatening conditions, as well as injuries, degenerative diseases, genetic disorders, and cancers. [Read more…]
Interview with Patrick Lucy, President and CEO of Lykan Bioscience
This is an interview with Patrick Lucy, President and CEO of Lykan Bioscience. Lykan is an innovative cell therapy-focused contract development and manufacturing organization (CDMO) headquartered in Hopkinton, MA. In this interview, we discuss the vision of Lykan Bioscience, its innovative and agile approach to CDMO services, and the company’s future goals. Enjoy! [Read more…]
Celularity – Big Bucks, Billionaire Investors, Bold Dreams
Celularity is a biotechnology company that specializes in leveraging biologically active cell populations within the postpartum human placenta. Founded on the pioneering work of Robert Hariri, MD, PhD, in human placenta-derived cellular therapeutics and biomaterials, Celularity is uniquely positioned to harness the potential of most biocreative event on earth: human birth. [Read more…]
Stem Cell Injection For Knee Pain, Arthritis, Tendonitis, And Joints
Stem cell injections are an intriguing treatment option for different conditions such as knee pain, osteoarthritis, and tendonitis. While the science and technology behind this approach are early-stage, they are advancing at a rapid rate. Learn how it works and how stem cell injections may be able to help manage joint pain.
Stem Cell Injections for Joint Pain
In This Article:
The Dominance of Cell and Gene Therapy CDMOS in 2023
While there are many exciting market segments, the market for cell and gene therapy CDMO services is one of the most fascinating. A decade ago, there were only a handful of market competitors. Today as we approach 2023, there are more than a hundred companies specializing in manufacturing and clinical trial support for cell and gene therapies (CGT)—and demand for their services continues to rise. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 41
- Next Page »
